FMOL Health | Our Lady of the Lake Cancer Institute announced the appointment of Nakhle Saba, MD, as its new Chief of Medical Oncology and Heme-Malignancy. In this role, Saba will help guide the clinical and strategic direction of the Cancer Institute, supporting physician engagement, advancing research initiatives, and strengthening academic partnerships.
Since joining the Cancer Institute in 2023, Saba has served as Director of Lymphoma, CLL, and CAR-T, where he has been instrumental in advancing innovative cancer treatments and clinical research. He established Louisiana's first outpatient CAR-T program and has played a key role in the strategic development of the multimillion-dollar Cancer Institute renovation project announced earlier this year.
Saba led an independently funded translational research laboratory as a professor of medicine at Tulane University School of Medicine and completed specialized training in lymphoid malignancies at the National Institutes of Health (NIH). He currently serves as a professor of medicine at the Louisiana State University (LSU) School of Medicine and plays an active role in several national oncology organizations, including the American Society of Hematology (ASH), the Center for International Blood and Marrow Transplant Research (CIBMTR) and the Southwest Oncology Group (SWOG). His work has contributed to significant advances in blood cancer research, clinical trials and innovative treatment approaches.
